Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Items 601–700 of 797
Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants
Yang, L., Li, Y., Bhattacharya, A., & Zhang, Y. (2021) · Communications Biology · doi:10.1038/s42003-021-02880-x · Cited by 7
The Four Homeostasis Knights: In Balance upon Post-Translational Modifications
Pieroni, S., Castelli, M., Piobbico, D., Ferracchiato, S., Scopetti, D., Di-Iacovo, N., Fazia, M. A. D., & Servillo, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214480 · Cited by 6
Flores-López, L. A., Enríquez‐Flores, S., Mora, I. D. L. M. L., García‐Torres, I., López‐Velázquez, G., Viedma‐Rodríguez, R., Ávalos‐Rodríguez, A., Contreras‐Ramos, A., & Ortega‐Camarillo, C. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13317 · Cited by 10
Lee, J.-D., Jung, H., & Min, S. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3722 · Cited by 6
“Several PRL-interacting proteins such as activating transcription factor-7, β-subunit of geranylgeranyl transferase-II, cadherin 22, ezrin, elongation factor 2, keratin 8, integrin-α1, PRL-1 (trimer), PRL-3 (oligomer) and FKBP8 have been reported (1,11,16,20-27).”
Positive effect of Mdm2 on p53 expression explains excitability of p53 in response to DNA damage
Eliaš, J. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.01.038 · Cited by 6
Sun, L., & Büeler, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.051 · Cited by 6
Fast friends – Ubiquitin-like modifiers as engineered fusion partners
Asimaki, E., Petriukov, K. S., Renz, C., Meister, C., & Ulrich, H. D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.11.013 · Cited by 10
“To dissect the role of p53 monoubiquitylation in this process, Li et al. created a linear fusion of ubiquitin to the C-terminus of p53 [122].”
Zhao, H., Wei, J., Du, Y., Chen, P., Liu, X., Liu, H., & Initiative, A. D. N. (2022) · Aging Cell · doi:10.1111/acel.13601 · Cited by 5
“Through the carboxyl-terminus of P53 and the DNA-binding domain of DMP1, DMP1 and P53 can interact directly in mammalian cells, then DMP1 antagonized P53 ubiquitination and promoted P53 nuclear localization (Braithwaite et al., 2006; Frazier et al., 2012; Li et al., 2003).”
p53 Tumor Suppressor: Functional Regulation and Role in Gene Therapy
Farooq, Z., Wani, S., Ragunathrao, V. A. B., Kochhar, R. K., & Anwar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105029 · Cited by 8
Deciphering p53 dynamics and cell fate in DNA damage response using mathematical modeling
Yang, N., Sun, T., & Shen, P. (2020) · Genome Instability & Disease · doi:10.1007/s42764-020-00019-6 · Cited by 7
Li, K., Kang, J., Zhāng, P., et al. (2015) · Oncology Letters · doi:10.3892/ol.2015.3054 · Cited by 6
“Furthermore, normal cells have a complete ubiquitin degradation system for the p53 protein, therefore, any small amount of exogenous p53 protein that is expressed will be quickly degraded (23).”
BackgroundThe multifunctional proline-rich domain of p53 tumor suppressor
Zhang, Y., & Dutta, M. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189326 · Cited by 8
Proteasomal control of transcription factors: mechanisms, regulation and dysregulation
Larsen, F. B., Kragelund, B. B., Lindorff‐Larsen, K., Heidarsson, P. O., & Hartmann‐Petersen, R. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06103-6 · Cited by 8
“Conversely, when p53 levels are high this will result in an increased expression of MDM2 , in turn leading to p53 polyubiquitylation and degradation [122].”
USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity
Choi, Y.-S., Lee, Y., Kim, J. S., Zhang, P., & Kim, J. (2023) · Biomolecules · doi:10.3390/biom13101475 · Cited by 5
“The pattern of endogenous ubiquitination of ETS2 was comparable to that of other proteins, such as p53 [25] and AT3 [26], both of which demonstrated primarily mono-ubiquitination.”
BackgroundPathophysiology of Cancer Cell Death
Galluzzi, L., Linkermann, A., Kepp, O., & Kroemer, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00005-0 · Cited by 8
Oscillation induced by Hopf bifurcation in the p53–Mdm2 feedback module
Gao, C., Ji, J., Yan, F., & Liu, H. (2019) · IET Systems Biology · doi:10.1049/iet-syb.2018.5092 · Cited by 5
“The inactive p53 is degraded rapidly by Mdm2 while p53* is degraded with a slower rate [39, 40].”
BackgroundTRANSCRIPTION FACTORS AND HUMAN DISEASE
Latchman, D. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012373983-4.50017-1 · Cited by 7
Novel Activators of the Tumour Suppressor p53
Sunder‐Plassmann, N., & Giannis, A. (2004) · ChemBioChem · doi:10.1002/cbic.200400194 · Cited by 5
Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53
Wei, Q., Li, C., Tang, Y., Bai, J., Wang, L., Liu, J., Su, Z., & Cheng, X. (2025) · Biomolecules · doi:10.3390/biom15050642 · Cited by 4
“Additionally, Mdm2, possessing E3 ubiquitin ligase activity, promotes the ubiquitin-proteasomal degradation of p53 upon binding to its N-terminal TAD [6,7].”
An optical and non‐invasive method to detect the accumulation of ubiquitin chains
Imai, J., Koganezawa, Y., Tuzuki, H., Ishikawa, I., & Sakai, T. (2019) · Cell Biology International · doi:10.1002/cbin.11186 · Cited by 4
Su, H., Ye, C., Sands, J. M., & Zhang, C. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00316.2019 · Cited by 4
Androgen receptor post-translational modifications and their implications for pathology
Montoya-Novoa, I., Gardeazábal-Torbado, J. L., Alegre‐Martí, A., Fuentes‐Prior, P., & Estébanez‐Perpiñá, E. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231082 · Cited by 4
The role of p53 in pancreatic β-cell apoptosis
Ortega‐Camarillo, C., Flores-López, L. A., & Ávalos‐Rodríguez, A. (2015) · Immunoendocrinology · doi:10.14800/ie.1075 · Cited by 5
“P53 mono and/or polyubiquitylation is determined by Mdm2 concentration and activation ([23]).”
Backgroundp53 regulation by ubiquitin and ubiquitin-like modifications
Wang, Y., Zhang, C., Wang, J., & Liu, J. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00067-0 · Cited by 5
Hammad, A. M., Alzaghari, L. F., Alfaraj, M., Al-Shawaf, L., & Sunoqrot, S. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01331-w · Cited by 4
Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53
Strachotová, D., Holoubek, A., Wolfová, K., Brodská, B., & Heřman, P. (2023) · FEBS Journal · doi:10.1111/febs.16810 · Cited by 4
Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53
Xirodimas, D. P., & Scheffner, M. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_10 · Cited by 5
Ma, X., Huang, X., Jiao, Z., He, L., Li, Y., & Ow, D. W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.054 · Cited by 4
Computer Simulations of Peptides from the p53 DNA Binding Domain
Khalili, M., & Wales, D. J. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct8005387 · Cited by 4
Ganesan, I. P., & Kiyokawa, H. (2025) · Cancers · doi:10.3390/cancers17040626 · Cited by 4
Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells
Miciak, J. J., Petrova, L., Sajwan, R., Pandya, A., Deckard, M., Munoz, A. J., & Bunz, F. (2025) · Oncotarget · doi:10.18632/oncotarget.28690 · Cited by 5
“In unstimulated cells with low p53 and low MDM2, the nuclear export of p53 is mediated by MDM2-mediated mono-ubiquitination [25].”
Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies
Wu, H. H., Leng, S., Eisenstat, D. D., Sergi, C. M., & Leng, R. P. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00907-x · Cited by 6
“MDM2 mediates mono-or multiple ubiquitination of p53 [89], but only polyu-biquitin chains are efficiently recognized by the proteasome [8].”
Yin, J., Zhou, Q., Tan, J., Che, W., & He, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-21986-1 · Cited by 3
Hu, Z., Zhang, X., Yang, H., Qin, S., Liu, Y., Xiong, W., Yuan, B., Li, L., Yao, W., & Wu, D. (2017) · Oncology Letters · doi:10.3892/ol.2017.7205 · Cited by 4
“MDM2 may negatively regulate the transcriptional activity of p53 by monoubiquitin to trigger p53 from nuclear exportation (34).”
BackgroundMillado, J. B. H., Hamajima, R., Sugiura, W., Makino, S., Kobayashi, M., & Ikeda, M. (2021) · Journal of insect biotechnology and sericology · doi:10.11416/jibs.90.2_021 · Cited by 3
A Narrative Review of the TP53 and Its Product the p53 Protein
Foroutan, B. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302185 · Cited by 9
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 8
“MDM2 and the E3 ligase MSL2 (male specifi c lethal 2) are both proposed to monoubiquitylate p53 to promote mitochondrial localization [ 121 – 123 ].”
BackgroundPlatta, H. W., Thoms, S., Kunau, W., & Erdmann, R. (2007) · The Enzymes · doi:10.1016/s1874-6047(07)25021-8 · Cited by 3
Jasti, N., Sebagh, D., Riaz, M., Wang, X., Koripella, B., Palanisamy, V., Mohammad, N., Chen, Q., & Friedrich, M. (2020) · Development Genes and Evolution · doi:10.1007/s00427-020-00663-8 · Cited by 3
“…E3 ubiquitin ligase, Mdm2 marks P53 with poly-ubiquitylation for destruction in the 26S proteasome (Hochstrasser 1996; Haupt et al. 1997; Wade et al. 2013); (II) Mono-ubiquitylation by Mdm2 modulates P53’s nuclear localization, and thus transcriptional activation potential (Li et al. 2003).”
BackgroundPathophysiology of Cancer Cell Death
Galluzzi, L., Kepp, O., & Kroemer, G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00005-9 · Cited by 6
RING Fingers and Relatives: Determinators of Protein Fate
Lorick, K. L., Tsai, Y. C., Yang, Y., & Weissman, A. M. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch4 · Cited by 3
Alshammari, Q. A., Alshammari, S. O., Alshammari, A., Alfarhan, M., & Baali, F. H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03564-z · Cited by 3
“The growth factor stimulation decreased phosphatase activity, which hindered the p53-mediated G1 arrest in inhibited GB. Additionally, a conditional release of MKP1 was seen to impede the growth of halted human cancerous cells into the cell cycle (Li et al. 2003b).”
Wang, Z., Liu, Y., Zhang, Y., Shi, J., Xie, S., Yi, M., Zhang, X., Tao, D., & Yang, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07694-x · Cited by 4
“Meanwhile, we performed immuno fl uorescence analysis and nucleocytoplasmic separation examination and observed that the downregulation of G3BP1 in TSPYL5-overexpressing SK-N-SH cells decreased the nuclear export of p53 and that G3BP1 overexpression increased the nuclear export of p53 in…”
The evolution of Nutlins as p53-MDM2 inhibitors
Bazanov, D. R., & Lozinskaya, N. A. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03492-4 · Cited by 4
“Studies show that low MDM2 activity leads to p53 monoubiquitination and nuclear export, whereas high MDM2 activity causes polyubiquitination and proteasomal degradation [18].”
Blondelle, J., & Lange, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-15263-9_12 · Cited by 2
Cooperation between MDM2 and MDMX in the Regulation of p53
Blaydes, J. P. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_6 · Cited by 3
Kofod‐Olsen, E., Pettersson, S., Wallace, M., Abduljabar, A. B., Øster, B., Hupp, T. R., & Höllsberg, P. (2013) · Virology · doi:10.1016/j.virol.2013.10.002 · Cited by 2
Mutant p53 Located in the Cytoplasm Inhibits Autophagy
Hernández‐Cáceres, M. P., Oses, C., Peña, D., Criollo, A., & Morselli, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802936-7.00010-6 · Cited by 3
The synthesis and characterization of tetramic acid derivatives as Mdm2-p53 inhibitors
Muszak, D., Łabuzek, B., Brela, M. Z., Twarda‐Clapa, A., Czub, M., Musielak, B., Surmiak, E., & Holak, T. A. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.03.089 · Cited by 3
Sivoňová, M. K., Jurečeková, J., Kaplán, P., Híveš, M., Grendár, M., Tomašcová, A., Dusenka, R., Drobková, H., Evin, D., & Kliment, J. (2020) · Anticancer Research · doi:10.21873/anticanres.14646 · Cited by 3
Neural Stem Cell Death Regulation in Nervous System Development and Disease
Walls, K. C., & Roth, K. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3801-4_7 · Cited by 2
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 3
P53, ROS: Redox Regulation Signaling, Metabolic Reprogramming, and Autophagy in Cancer
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_7 · Cited by 3
Does Corporate Social Responsibility Influence Corporate Innovation?
Ali, M. M., Hassen, M., & Sheikh, S. S. (2024) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-80455-406-720241016 · Cited by 2
Sabadini, G., Mellado, M., Morales-Verdejo, C. A., & Mella, J. (2024) · Pharmaceuticals · doi:10.3390/ph17050606 · Cited by 3
“This process inhibits apoptosis [36] and theoretically could promote cancer development.”
BackgroundDong, Y., & Zou, S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_5 · Cited by 2
“Acetylation of p53 at multiple sites is thought to stabilize the molecule, preserve its active function, and thereby trigger apoptosis and cell-cycle arrest (Li et al. 2002; Gostissa et al. 2003; Li et al. 2003).”
BackgroundUbiquitin Signaling and Cancer Pathogenesis
Haglund, K., & Đikić, I. (2007) · Wiley eBooks · doi:10.1002/9783527620234.ch1 · Cited by 2
Set the Tone: Make It Safe to Be Vulnerable
(2018) · Yale University Press eBooks · doi:10.2307/j.ctvqc6gvg.12 · Cited by 2
ESF1 positively regulates MDM2 and promotes tumorigenesis
Zhang, P., Sun, C., Yin, T., Guo, J., Chong, D., Tang, Y., Liu, Y., Li, Y., Gu, Y., & Lü, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133652 · Cited by 1
Insulin receptor tyrosine kinase substrate in health and disease (Review)
Zhang, X., & Zhang, Z. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13437 · Cited by 1
Jo, S.-R., Kim, J. S., Baek, S. H., & Jang, Y. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-30772-1 · Cited by 4
MDM2/p53-based live-cell quantitative FRET imaging for apoptosis drug discovery
Xiao, Z., Xie, L., Wu, Z., Cai, X., Zhuang, Z., & Chen, T. (2025) · Methods · doi:10.1016/j.ymeth.2025.12.002 · Cited by 1
Jab1 has negative effects on p53-mediated genotoxic stresses
Lee, E., Lee, S.-S., & Song, J.-W. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.5.299 · Cited by 1
Tsai, W., & Barton, M. C. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_23 · Cited by 1
Lukaesko, L., & Meller, R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6382-6_12 · Cited by 1
p53 TAD2 Domain (38–61) Forms Amyloid-like Aggregates in Isolation
Gadhave, K., Kapuganti, S. K., Mishra, P. M., & Giri, R. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00860 · Cited by 1
du Toit-Kohn, J.-L. (2006) · SUNScholar (Stellenbosch University) · Cited by 1
Complex regulation of Forkhead Box O transcription factors
van den Berg, M. C. W. (2013) · Utrecht University Repository (Utrecht University) · Cited by 1
p53‐mediated Apoptosis: A Multifaceted Story
Speidel, D., & Deppert, W. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch19 · Cited by 2
The anoxia resistant crayfish : a profile of stress response
Lant, B. (2011) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2011-09542 · Cited by 2
COP1 contributes to UVB-induced signaling in human keratinocytes
Kinyó, Á. (2011) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.754 · Cited by 1
Modeling wild type and mutant p53 in telomerase-immortalized human cellsPreprint
Miciak, J. J., & Bunz, F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.22.546141 · Cited by 1
Ubiquitination mediates protein localization in RNA virus-infected cellsPreprint
Shi, S., Iešmantavičius, V., Sabu, A. S., Soneson, C., Kohler, H., Sanchez, J., Ghosh, S., Cao, C., Huang, Y., Matthias, G., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.15.608034 · Cited by 1
The regulation of preadipocyte differentiation by glucocorticoids
Tomlinson, J. J. (2007) · uO Research (University of Ottawa) · doi:10.20381/ruor-13103
Roh, J.-L., & Koch, W. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8815-6_12
Ubiquitination and deubiquitination involved in cell cycle progression
van Leuken, R. J. (2008) · Utrecht University Repository (Utrecht University)
The role of TRIM39 in cell cycle and apoptosis
Huang, N.-J. (2013) · DukeSpace (Duke University)
Global and specific controls of protein synthesis in hibernators
Pan, P. (2011) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/3295694
Tumor Suppressor p53: A Multifunctional Protein Implicated in Seizure-Induced Neuronal Cell Death
Tan, Z., & Schreiber, S. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-73226-8_15
“Recent studies indicate that monoubiquitination of p53 may regulate nuclear export without affecting p53 degradation (Li et al. 2003).”
BackgroundCharacterization of the Ubc13-Mms2 Lysine-63-linked ubiquitin conjugating complex
Pastushok, L. (2006) · University Library - University of Saskatchewan (University of Saskatchewan)
The effect of Kaposi's sarcoma-associated herpesvirus RTA expression upon the cellular proteome
Wood, J. J. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Prenatal Diagnosis and the Spectrum of Involvement from Fragile X Mutations
Hagerman, R. J., Narcisa, V., & Hagerman, P. J. (2009) · Wiley eBooks · doi:10.1002/9781444314342.ch9
Regulation of the p53 Tumor‐Suppressor Protein by Ubiquitin and Ubiquitin‐Like Molecules
Xirodimas, D. P. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch2c
Multiple modes of Mdmx regulation affect p53 activation
Gilkes, D. M. (2008) · Digital Commons - University of South Florida (University of South Florida)
Touqan, N. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
Molecular mechanisms of growth suppression by pharmacologically activated p53
Hedström, E. (2009) · Figshare
Sarek, G. (2010) · Helda - University of Helsinki Institutional Repository
Doxycyclin induces p53 expression in SaOs (osteosarcoma) cell line
Obasuyi, O. (2015) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v9i1.37
DNA Damage-Induced Apoptosis in the Presence and Absence of the Tumor Suppressor p53: A Dissertation
McNamee, L. M. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/y5k8-fb94
“In unstressed cells, Mdm-2 can monoubiquinate p53, which allows for p53 to be exported from the nucleus, or it can polyubiquinate p53, resulting in proteasomal degradation (Li et al. 2003; Carter et al. 2007).”
Regulation of FOXO stability and activity by MDM2 E3 ligase
Fu, W. (2007) · Digital Commons - University of South Florida (University of South Florida)
Intracellular mechanisms of apoptosis induced by aminoglycoside antibiotics
Denamur, S. (2013) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))
Plessl, T. (2013) · University of Vienna · doi:10.25365/thesis.27688
Bhat, K. P. (2010) · Digital Archive @ GSU · doi:10.57709/1338636 · Cited by 1
Post-translational Modifications of the p53 Transcription Factor
Brooks, C. L., & Gu, W. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_15
Self-citationMarques, Y. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.23.2006.tde-19032007-170028
p53 activity during adenovirus infection
Savelyeva, I. V. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-366
Analysis of p53 and c-MYC, two key transcription factors involved in tumorigenesis
Jung, P. (2008) · doi:10.5282/edoc.10559 · Cited by 1
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.